Ageas
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
27 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
May 23, 2018 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| May 29, 2023 | Citadel Advisors Europe Limited | 0.50% | still open |
| May 25, 2023 | Citadel Advisors Europe Limited | 0.50% | still open |
| March 31, 2023 | Citadel Advisors Europe Limited | 0.50% | still open |
| October 27, 2022 | Marshall Wace LLP | 0.51% | November 11, 2022 |
| February 1, 2022 | Citadel Advisors Europe Limited | 0.50% | February 18, 2022 |
| February 19, 2020 | Citadel Europe LLP | 0.53% | February 20, 2020 |
| January 15, 2020 | Citadel Europe LLP | 0.68% | February 19, 2020 |
| December 9, 2019 | Citadel Europe LLP | 0.70% | January 15, 2020 |
| November 1, 2019 | Citadel Europe LLP | 0.75% | December 9, 2019 |
| October 22, 2019 | Citadel Europe LLP | 0.80% | November 1, 2019 |
| October 10, 2019 | Citadel Europe LLP | 0.71% | October 22, 2019 |
| September 24, 2019 | Citadel Europe LLP | 0.60% | October 10, 2019 |
| November 19, 2018 | Boussard & Gavaudan Investment Management LLP | 0.51% | November 20, 2018 |
| November 16, 2018 | Boussard & Gavaudan Investment Management LLP | 0.60% | November 19, 2018 |
| November 14, 2018 | Boussard & Gavaudan Investment Management LLP | 0.73% | November 16, 2018 |
| November 13, 2018 | Boussard & Gavaudan Investment Management LLP | 0.68% | November 14, 2018 |
| November 11, 2018 | Boussard & Gavaudan Investment Management LLP | 0.71% | November 13, 2018 |
| November 8, 2018 | Boussard & Gavaudan Investment Management LLP | 0.69% | November 12, 2018 |
| October 25, 2018 | Boussard & Gavaudan Investment Management LLP | 0.77% | November 8, 2018 |
| October 15, 2018 | Boussard & Gavaudan Investment Management LLP | 0.89% | October 25, 2018 |
| October 11, 2018 | Boussard & Gavaudan Investment Management LLP | 0.90% | October 13, 2018 |
| September 21, 2018 | Boussard & Gavaudan Investment Management LLP | 0.82% | October 11, 2018 |
| July 13, 2018 | Marshall Wace LLP | 0.62% | July 25, 2018 |
| June 25, 2018 | Boussard & Gavaudan Investment Management LLP | 0.70% | September 21, 2018 |
| June 1, 2018 | Boussard & Gavaudan Investment Management LLP | 0.61% | June 25, 2018 |
| May 24, 2018 | Boussard & Gavaudan Investment Management LLP | 0.52% | June 1, 2018 |
| May 23, 2018 | Citadel Europe LLP | 0.50% | May 24, 2018 |
Other companies sold short in Belgium
- Solvay 2.07% of the capital sold short
- Biocartis 1.21% of the capital sold short
- Barco 1.02% of the capital sold short
- CP Invest 0.98% of the capital sold short
- D'Ieteren Group 0.89% of the capital sold short
- Syensqo 0.89% of the capital sold short
- EVS 0.80% of the capital sold short
- Azelis 0.71% of the capital sold short
- Umicore 0.70% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- WDP 0.51% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Ageas, source FSMA, data as at May 29, 2023, https://www.quivad.com/action/ageas